1-20 of 458
heart disease risk factors
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cardiovascular and Renal Benefits of Novel Diabetes Drugs by Baseline Cardiovascular Risk: A Systematic Review, Meta-analysis, and Meta-regression

José M. Rodriguez-Valadez, Malak Tahsin, Kirsten E. Fleischmann, Umesh Masharani, Joseph Yeboah, Meyeon Park, Lihua Li, Ellerie Weber, Yan Li, Asem Berkalieva, Wendy Max, M.G. Myriam Hunink, Bart S. Ferket
Journal: Diabetes Care
Diabetes Care 2023;46(6):1300–1310
DOI: https://doi.org/10.2337/dc22-0772
Published: 23 May 2023
View article titled, Cardiovascular and Renal Benefits of Novel Diabetes Drugs by Baseline Cardiovascular Risk: A Systematic Review, Meta-analysis, and Meta-regression
Open the PDF for Cardiovascular and Renal Benefits of Novel Diabetes Drugs by Baseline Cardiovascular Risk: A Systematic Review, Meta-analysis, and Meta-regression in another window
Journal Articles

In This Issue of Diabetes Care

Max Bingham, PhD
Journal: Diabetes Care
Diabetes Care 2023;46(5):902–903
DOI: https://doi.org/10.2337/dc23-ti05
Published: 26 April 2023
View article titled, In This Issue of Diabetes Care
Open the PDF for In This Issue of Diabetes Care in another window
Journal Articles

Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety Study

Huan Wang, Ruth L.M. Cordiner, Yu Huang, Louise Donnelly, Simona Hapca, Andrew Collier, John McKnight, Brian Kennon, Fraser Gibb, Paul McKeigue, Sarah H. Wild, Helen Colhoun, John Chalmers, John Petrie, Naveed Sattar, Thomas MacDonald, Rory J. McCrimmon, Daniel R. Morales, Ewan R. Pearson, Scottish Diabetes Research Network Epidemiology Group , Luke Blackbourn, Scott Cunningham, Fraser Gibb, Graham Leese, Robert Lindsay, David McAllister, Stuart McGurnaghan, Sam Philip
Journal: Diabetes Care
Diabetes Care 2023;46(5):967–977
DOI: https://doi.org/10.2337/dc22-1238
Published: 21 March 2023
View article titled, Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety Study
Open the PDF for Cardiovascular Safety in Type 2 Diabetes With Sulfonylureas as Second-line Drugs: A Nationwide Population-Based Comparative Safety Study in another window
Journal Articles

Effects of Intensive Systolic Blood Pressure Lowering on End-Stage Kidney Disease and Kidney Function Decline in Adults With Type 2 Diabetes Mellitus and Cardiovascular Risk Factors: A Post Hoc Analysis of ACCORD-BP and SPRINT

Yahya M.K. Tawfik, Benjamin W. Van Tassell, Dave L. Dixon, William L. Baker, John Fanikos, Leo F. Buckley
Journal: Diabetes Care
Diabetes Care 2023;46(4):868–873
DOI: https://doi.org/10.2337/dc22-2040
Published: 14 February 2023
View article titled, Effects of Intensive Systolic Blood Pressure Lowering on End-Stage Kidney Disease and Kidney Function Decline in Adults With Type 2 Diabetes Mellitus and Cardiovascular Risk Factors: A Post Hoc Analysis of ACCORD-BP and SPRINT
Open the PDF for Effects of Intensive Systolic Blood Pressure Lowering on End-Stage Kidney Disease and Kidney Function Decline in Adults With Type 2 Diabetes Mellitus and Cardiovascular Risk Factors: A Post Hoc Analysis of ACCORD-BP and SPRINT in another window
Journal Articles

Association of Elevated Arterial Stiffness With Cardiac Target Organ Damage and Cardiac Autonomic Neuropathy in Young Adults With Diabetes: The SEARCH for Diabetes in Youth Study

Elaine M. Urbina, Scott Isom, Dana Dabelea, Ralph D’Agostino, Jr., Stephen R. Daniels, Lawrence M. Dolan, Giuseppina Imperatore, Eva Lustigova, Santica Marcovina, Amy Mottl, Catherine Pihoker, Amy S. Shah
Journal: Diabetes Care
Diabetes Care 2023;46(4):786–793
DOI: https://doi.org/10.2337/dc22-1703
Published: 02 February 2023
View article titled, Association of Elevated Arterial Stiffness With Cardiac Target Organ Damage and Cardiac Autonomic Neuropathy in Young Adults With Diabetes: The SEARCH for Diabetes in Youth Study
Open the PDF for Association of Elevated Arterial Stiffness With Cardiac Target Organ Damage and Cardiac Autonomic Neuropathy in Young Adults With Diabetes: The SEARCH for Diabetes in Youth Study in another window
Journal Articles

Growing Income-Related Disparities in Cardiovascular Hospitalizations Among People With Diabetes, 1995–2019: A Population-Based Study

Baiju R. Shah, Peter C. Austin, Calvin Ke, Lorraine L. Lipscombe, Alanna Weisman, Gillian L. Booth
Journal: Diabetes Care
Diabetes Care 2023;46(4):751–756
DOI: https://doi.org/10.2337/dc22-1936
Published: 31 January 2023
View article titled, Growing Income-Related Disparities in Cardiovascular Hospitalizations Among People With Diabetes, 1995–2019: A Population-Based Study
Open the PDF for Growing Income-Related Disparities in Cardiovascular Hospitalizations Among People With Diabetes, 1995–2019: A Population-Based Study in another window
Journal Articles

Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide

Robert E.J. Ryder, Katharina Laubner, Marek Benes, Martin Haluzik, Lynne Munro, Harry Frydenberg, Julian P. Teare, Aruchuna Ruban, Sigal Fishman, Erwin Santo, Rainer Stengel, Charlotte De Jonge, Jan W. Greve, Ricardo V. Cohen, Cristina M. Aboud, Gerald J. Holtmann, Graeme Rich, Jess J. McMaster, Tadej Battelino, Primoz Kotnik, James P. Byrne, John C. Mason, Justin Bessell, Jeanine Bascomb, Lillian Kow, Janes Collins, Jacob Chisholm, Peter N. Pferschy, Harald Sourij, Melissa L. Cull, Melanie C. Wyres, Russell Drummond, Barbara McGowan, Stephanie A. Amiel, Mahi Yadagiri, Piya Sen Gupta, Jens Aberle, Jochen Seufert
Journal: Diabetes Care
Diabetes Care 2023;46(4):e89–e91
DOI: https://doi.org/10.2337/dc22-1952
Published: 30 January 2023
View article titled, Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide
Open the PDF for Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide in another window
Journal Articles

10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023

Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, Raveendhara R. Bannuru, Florence M. Brown, Dennis Bruemmer, Billy S. Collins, Sandeep R. Das, Marisa E. Hilliard, Diana Isaacs, Eric L. Johnson, Scott Kahan, Kamlesh Khunti, Mikhail Kosiborod, Jose Leon, Sarah K. Lyons, Mary Lou Perry, Priya Prahalad, Richard E. Pratley, Jane Jeffrie Seley, Robert C. Stanton, Robert A. Gabbay
Journal: Diabetes Care
Diabetes Care 2023;46(Supplement_1):S158–S190
DOI: https://doi.org/10.2337/dc23-S010
Published: 12 December 2022
View article titled, 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023
Open the PDF for 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 in another window
Journal Articles

Immunoglobulin G N-Glycosylation Signatures in Incident Type 2 Diabetes and Cardiovascular Disease

Anna Birukov, Branimir Plavša, Fabian Eichelmann, Olga Kuxhaus, Rosangela Akemi Hoshi, Najda Rudman, Tamara Štambuk, Irena Trbojević-Akmačić, Catarina Schiborn, Jakub Morze, Matea Mihelčić, Ana Cindrić, Yanyan Liu, Olga Demler, Markus Perola, Samia Mora, Matthias B. Schulze, Gordan Lauc, Clemens Wittenbecher
Journal: Diabetes Care
Diabetes Care 2022;45(11):2729–2736
DOI: https://doi.org/10.2337/dc22-0833
Published: 25 October 2022
View article titled, Immunoglobulin G N-Glycosylation Signatures in Incident Type 2 Diabetes and Cardiovascular Disease
Open the PDF for Immunoglobulin G N-Glycosylation Signatures in Incident Type 2 Diabetes and Cardiovascular Disease in another window
Journal Articles

Use of the Steno T1 Risk Engine Identifies Preclinical Atherosclerosis Better Than Use of ESC/EASD-2019 in Adult Subjects With Type 1 Diabetes at High Risk

Tonet Serés-Noriega, Marga Giménez, Verónica Perea, Laura Boswell, Clara Viñals, Jesús Blanco, Irene Vinagre, Adriana Pané, Enric Esmatjes, Ignacio Conget, Antonio J. Amor
Journal: Diabetes Care
Diabetes Care 2022;45(10):2412–2421
DOI: https://doi.org/10.2337/dc22-0118
Published: 09 August 2022
View article titled, Use of the Steno T1 Risk Engine Identifies Preclinical Atherosclerosis Better Than Use of ESC/EASD-2019 in Adult Subjects With Type 1 Diabetes at High Risk
Open the PDF for Use of the Steno T1 Risk Engine Identifies Preclinical Atherosclerosis Better Than Use of ESC/EASD-2019 in Adult Subjects With Type 1 Diabetes at High Risk in another window
Journal Articles

Serum Orotidine: A Novel Biomarker of Increased CVD Risk in Type 2 Diabetes Discovered Through Metabolomics Studies

Hetal S. Shah, Lorena Ortega Moreno, Mario Luca Morieri, Yaling Tang, Christine Mendonca, Jenny Marie Jobe, Jonathan B. Thacker, Joanna Mitri, Stefano Monti, Monika A. Niewczas, Subramaniam Pennathur, Alessandro Doria
Journal: Diabetes Care
Diabetes Care 2022;45(8):1882–1892
DOI: https://doi.org/10.2337/dc21-1789
Published: 26 July 2022
View article titled, Serum Orotidine: A Novel Biomarker of Increased CVD Risk in Type 2 Diabetes Discovered Through Metabolomics Studies
Open the PDF for Serum Orotidine: A Novel Biomarker of Increased CVD Risk in Type 2 Diabetes Discovered Through Metabolomics Studies in another window
Journal Articles

Clinical Utility of Cardiovascular Risk Scores for Identification of People With Type 2 Diabetes More Likely to Benefit From Either GLP-1 Receptor Agonist or SGLT2 Inhibitor Therapy

Julian W. Sacre, Dianna J. Magliano, Jonathan E. Shaw
Journal: Diabetes Care
Diabetes Care 2022;45(8):1900–1906
DOI: https://doi.org/10.2337/dc21-1929
Published: 26 July 2022
View article titled, Clinical Utility of Cardiovascular Risk Scores for Identification of People With Type 2 Diabetes More Likely to Benefit From Either GLP-1 Receptor Agonist or SGLT2 Inhibitor Therapy
Open the PDF for Clinical Utility of Cardiovascular Risk Scores for Identification of People With Type 2 Diabetes More Likely to Benefit From Either GLP-1 Receptor Agonist or SGLT2 Inhibitor Therapy in another window
Journal Articles

Association Between Insulin Resistance and Cardiovascular Disease Risk Varies According to Glucose Tolerance Status: A Nationwide Prospective Cohort Study

Tiange Wang, Mian Li, Tianshu Zeng, Ruying Hu, Yu Xu, Min Xu, Zhiyun Zhao, Yuhong Chen, Shuangyuan Wang, Hong Lin, Xuefeng Yu, Gang Chen, Qing Su, Yiming Mu, Lulu Chen, Xulei Tang, Li Yan, Guijun Qin, Qin Wan, Zhengnan Gao, Guixia Wang, Feixia Shen, Zuojie Luo, Yingfen Qin, Li Chen, Yanan Huo, Qiang Li, Zhen Ye, Yinfei Zhang, Chao Liu, Youmin Wang, Shengli Wu, Tao Yang, Huacong Deng, Jiajun Zhao, Lixin Shi, Guang Ning, Yufang Bi, Weiqing Wang, Jieli Lu
Journal: Diabetes Care
Diabetes Care 2022;45(8):1863–1872
DOI: https://doi.org/10.2337/dc22-0202
Published: 26 July 2022
View article titled, Association Between Insulin Resistance and Cardiovascular Disease Risk Varies According to Glucose Tolerance Status: A Nationwide Prospective Cohort Study
Open the PDF for Association Between Insulin Resistance and Cardiovascular Disease Risk Varies According to Glucose Tolerance Status: A Nationwide Prospective Cohort Study in another window
Journal Articles

Remnant Cholesterol and Its Visit-to-Visit Variability Predict Cardiovascular Outcomes in Patients With Type 2 Diabetes: Findings From the ACCORD Cohort

Liyao Fu, Shi Tai, Jiaxing Sun, Ningjie Zhang, Ying Zhou, Zhenhua Xing, Yongjun Wang, Shenghua Zhou
Journal: Diabetes Care
Diabetes Care 2022;45(9):2136–2143
DOI: https://doi.org/10.2337/dc21-2511
Published: 14 July 2022
View article titled, Remnant Cholesterol and Its Visit-to-Visit Variability Predict Cardiovascular Outcomes in Patients With Type 2 Diabetes: Findings From the ACCORD Cohort
Open the PDF for Remnant Cholesterol and Its Visit-to-Visit Variability Predict Cardiovascular Outcomes in Patients With Type 2 Diabetes: Findings From the ACCORD Cohort in another window
Journal Articles

Rural-Urban Differences in Diabetes Care and Control in 42 Low- and Middle-Income Countries: A Cross-sectional Study of Nationally Representative Individual-Level Data

David Flood, Pascal Geldsetzer, Kokou Agoudavi, Krishna K. Aryal, Luisa Campos Caldeira Brant, Garry Brian, Maria Dorobantu, Farshad Farzadfar, Oana Gheorghe-Fronea, Mongal Singh Gurung, David Guwatudde, Corine Houehanou, Jutta M. Adelin Jorgensen, Dimple Kondal, Demetre Labadarios, Maja E. Marcus, Mary Mayige, Mana Moghimi, Bolormaa Norov, Gastón Perman, Sarah Quesnel-Crooks, Mohammad-Mahdi Rashidi, Sahar Saeedi Moghaddam, Jacqueline A. Seiglie, Silver K. Bahendeka, Eric Steinbrook, Michaela Theilmann, Lisa J. Ware, Sebastian Vollmer, Rifat Atun, Justine I. Davies, Mohammed K. Ali, Peter Rohloff, Jennifer Manne-Goehler
Journal: Diabetes Care
Diabetes Care 2022;45(9):1961–1970
DOI: https://doi.org/10.2337/dc21-2342
Published: 30 June 2022
View article titled, Rural-Urban Differences in Diabetes Care and Control in 42 Low- and Middle-Income Countries: A Cross-sectional Study of Nationally Representative Individual-Level Data
Open the PDF for Rural-Urban Differences in Diabetes Care and Control in 42 Low- and Middle-Income Countries: A Cross-sectional Study of Nationally Representative Individual-Level Data in another window
Journal Articles

Efficacy and Safety of K-877 (Pemafibrate), a Selective PPARα Modulator, in European Patients on Statin Therapy

Henry N. Ginsberg, Neil J. Hounslow, Yusuke Senko, Hideki Suganami, Pawel Bogdanski, Richard Ceska, Akos Kalina, Roman A. Libis, Tatiana V. Supryadkina, G. Kees Hovingh
Journal: Diabetes Care
Diabetes Care 2022;45(4):898–908
DOI: https://doi.org/10.2337/dc21-1288
Published: 25 March 2022
View article titled, Efficacy and Safety of K-877 (Pemafibrate), a Selective PPARα Modulator, in European Patients on Statin Therapy
Open the PDF for Efficacy and Safety of K-877 (Pemafibrate), a Selective PPARα Modulator, in European Patients on Statin Therapy in another window
Journal Articles

Longitudinal Association of Depressive Symptoms, Binge Eating, and Quality of Life With Cardiovascular Risk Factors in Young Adults With Youth-Onset Type 2 Diabetes: The TODAY2 Study

TODAY Study Group
Journal: Diabetes Care
Diabetes Care 2022;45(5):1073–1081
DOI: https://doi.org/10.2337/dc21-1995
Published: 15 March 2022
View article titled, Longitudinal Association of Depressive Symptoms, Binge Eating, and Quality of Life With Cardiovascular Risk Factors in Young Adults With Youth-Onset Type 2 Diabetes: The TODAY2 Study
Open the PDF for Longitudinal Association of Depressive Symptoms, Binge Eating, and Quality of Life With Cardiovascular Risk Factors in Young Adults With Youth-Onset Type 2 Diabetes: The TODAY2 Study in another window
Journal Articles

Association Between Team-Based Continuity of Care and Risk of Cardiovascular Diseases Among Patients With Diabetes: A Retrospective Cohort Study

Kam Suen Chan, Eric Yuk Fai Wan, Weng Yee Chin, Esther Yee Tak Yu, Ivy Lynn Mak, Will Ho Gi Cheng, Margaret Kay Ho, Cindy Lo Kuen Lam
Journal: Diabetes Care
Diabetes Care 2022;45(5):1162–1169
DOI: https://doi.org/10.2337/dc21-1217
Published: 09 March 2022
View article titled, Association Between Team-Based Continuity of Care and Risk of Cardiovascular Diseases Among Patients With Diabetes: A Retrospective Cohort Study
Open the PDF for Association Between Team-Based Continuity of Care and Risk of Cardiovascular Diseases Among Patients With Diabetes: A Retrospective Cohort Study in another window
Journal Articles

Estimated Life-Years Gained Free of New or Recurrent Major Cardiovascular Events With the Addition of Semaglutide to Standard of Care in People With Type 2 Diabetes and High Cardiovascular Risk

Jan Westerink, Kasper Sommer Matthiessen, Solomon Nuhoho, Udi Fainberg, Michael Lyng Wolden, Helena Bleken Østergaard, Frank Visseren, Naveed Sattar
Journal: Diabetes Care
Diabetes Care 2022;45(5):1211–1218
DOI: https://doi.org/10.2337/dc21-1138
Published: 09 March 2022
View article titled, Estimated Life-Years Gained Free of New or Recurrent Major Cardiovascular Events With the Addition of Semaglutide to Standard of Care in People With Type 2 Diabetes and High Cardiovascular Risk
Open the PDF for Estimated Life-Years Gained Free of New or Recurrent Major Cardiovascular Events With the Addition of Semaglutide to Standard of Care in People With Type 2 Diabetes and High Cardiovascular Risk in another window
Journal Articles

Lifetime Cardiovascular Disease Risk by Coronary Artery Calcium Score in Individuals With and Without Diabetes: An Analysis From the Multi-Ethnic Study of Atherosclerosis

Bart S. Ferket, M.G. Myriam Hunink, Umesh Masharani, Wendy Max, Joseph Yeboah, Gregory L. Burke, Kirsten E. Fleischmann
Journal: Diabetes Care
Diabetes Care 2022;45(4):975–982
DOI: https://doi.org/10.2337/dc21-1607
Published: 15 February 2022
View article titled, Lifetime Cardiovascular Disease Risk by Coronary Artery Calcium Score in Individuals With and Without Diabetes: An Analysis From the Multi-Ethnic Study of Atherosclerosis
Open the PDF for Lifetime Cardiovascular Disease Risk by Coronary Artery Calcium Score in Individuals With and Without Diabetes: An Analysis From the Multi-Ethnic Study of Atherosclerosis in another window